Multiple sclerosis (MS) is a disease of the central nervous system (CNS) leading to the demyelination of white and grey matter, 1 characterised initially in most patients by relapsing-remitting episodes.
severity of both active and adoptive EAE before or after disease onset. Thus, sex steroids exert beneficial effects for MS as shown in numerous studies. 7, 12, 13 It is well documented that the nervous system is capable of synthesising de novo bioactive steroids from cholesterol. One or more components of neurosteroidogenesis have been found in neurones, oligodendrocytes, astrocytes and microglia. [14] [15] [16] The steroid synthesising machinery involves the steroidogenic acute regulatory protein (StAR), which regulates cholesterol transfer within the mitochondria, and the transport of cholesterol via a channel composed of 18-kDa translocator protein (TSPO), the voltage-dependent anion channel (VDAC) plus some accessory proteins. Inside the mitochondria, the side chain cleavage enzyme (P450scc) converts cholesterol into pregnenolone, which is metabolised to progesterone by 3β-hydroxysteroid dehydrogenase/isomerase (3β-HSD). Progesterone is further reduced into dihydroprogesterone (DHP) by 5α-reductase and to allopregnanolone (ALLO) by 3α-hydroxysteroid dehydrogenase (3α-HSD) and is also the precursor for androgens, which are converted into oestrogens by the enzyme aromatase.
The neurosteroids influence the growth and survival of nerve cells during development and are involved in the regulation of various brain and peripheral nerve functions, including behavioural, neuroendocrine and metabolic processes in adults. 17 Therefore, altered levels of neurosteroids during development or in adults are associated with neurodevelopmental, psychiatric or behavioural disorders. In this sense, an emerging therapeutic role of steroids such as sulphated pregnanes, ALLO or other pharmacological strategies that enhance neurosteroidogenesis is considered to improve both emotional and cognitive behaviour in neuropsychiatric disorders. 18 Developmental myelination is also influenced by neurosteroids.
ALLO is present in high concentrations in late gestation. Preterm birth results in the delivery of neonates with reduced myelination in the cerebellum and immaturity of the oligodendrocyte lineage. 19 In turn, progesterone and its reduced metabolite ALLO stimulates myelination in organotypic cultures of rat cerebellum. 20 Moreover, oligodendrocytes and their precursors differentially express the enzymes needed for the synthesis of progesterone and its metabolites, suggesting a role for these compounds in oligodendrocyte proliferation and differentiation during development. 21 Androgens also show a promyelinating role because higher levels of male hormones associate with an increased expression of myelin proteins and oligodendrocyte density in the developing corpus callosum. 22 There is evidence in the literature to support changes of neurosteroids being involved in the pathophysiology of MS. Thus, the brain of MS patients and EAE animals displays reduced ALLO and dehydroepiandrosterone levels and diminished expression of their synthesising enzymes. 25, 26 Other studies have reported that progesterone and its reduced metabolites DHP and ALLO are altered in the cerebrospinal fluid and plasma of EAE rats and MS patients. 23, 24 Interestingly, in EAE models, reduced levels of neurosteroids are frequently associated with inflammation and myelin loss, 25, 26 whereas exogenous administration of progesterone or synthetic progestins prevents demyelination, enhances myelin repair and reduces CNS inflammation. 10, 27, 28 Furthermore, progesterone and the synthetic progestin Nestorone repair demyelinating lesions and increase oligodendrogenesis in the cuprizone model of MS. 29 Previous work in the EAE model has shown that progesterone treatment restores normal neurosteroidogenesis and decreases neuropathology at the spinal cord level. 10, 27, 30 In view of these reports, the present study investigated whether changes of neurosteroidogenesis also occurred in mice subjected to cuprizone-induced demyelination. Cuprizone-treated animals are characterised by initial oligodendrocyte death, as well as demyelination of neocortex, corpus callosum and hippocampus, together with recruitment of microglia/macrophages, astrocytes and oligodendrocyte progenitor cells (OPCs). 31 When the cuprizone diet is suspended and replaced with normal mice chow, oligodendrocytes are replenished and axons become remyelinated. 32 To analyse events at these different periods, we compared the expression of neurosteroidogenic proteins and enzymes and the glial reaction after cuprizone-induced demyelination and during the remyelination stage. We found that neurosteroidogenesis/myelination status and micro/astroglial reactivity are inversely related in the hippocampus and neocortex, suggesting an association of enhanced neurosteroidogenesis with remyelination. 
| MATERIAL S AND ME THODS

| Experimental animals and cuprizone treatment
| Real-time polymerase chain reaction (PCR)
For real-time PCR, mice were deeply anaesthetised with a mixture of xylazine (6 mg 
| Histology and immunohistochemistry
Animals were deeply anaesthetised with a mixture of xylazine 
| Microscopy and quantitative analysis
We analysed every eighth section spanning the rostrocaudal ex- 
| Statistical analysis
Group comparisons were carried out using ANOVA followed by a Newman-Keuls post-hoc test. P < 0.05 was considered statistically significant. Statistics were performed using prism, version 4 (GraphPad Inc., La Jolla, CA, USA).
| RE SULTS
As already noted, cuprizone treatment produces demyelination of different brain areas, whereas spontaneous remyelination develops after removal of the toxic insult. 35 Therefore, we studied changes of neurosteroidogenic proteins and enzymes during demyelination and remyelination in three different brain areas: the hippocampus, corpus callosum and cortex. The response of astrocytes, microglia
and TNFα was also determined as a result of their crucial role in the pathology produced by cuprizone administration. Thus, increased expression of the microglia marker CD11b mRNA and higher number of IBA1+ cells were found in the hippocampus of CPZ D mice compared to CTLR groups (P < 0.01 and P < 0.001, respectively) ( Figure 1D ,E). Conversely, both parameters were reduced during remyelination (CPZ R vs CPZ D mice: P < 0.05
for CD11b mRNA and P < 0.01 for IBA1+ cells) ( Figure 1D,E) .
Hippocampal neurosteroidogenic protein and enzymes in the three experimental groups. A, Levels of steroidogenic acute regulatory protein (StAR) mRNA were decreased in demyelinated (cuprizone [CPZ] D) mice (**P < 0.01 vs control) and restored to control (CTRL) levels in the remyelinated (CPZ R) group (**P < 0.01 vs CPZ D). B, StAR immunoreactive area in the CA3 region of the hippocampus was decreased in CPZ D mice and increased in the CPZ R group (*P < 0.5 vs CPZ D; not significant vs CTRL). C, Photomicrographs taken from hippocampal CA3 region of CTRL (left) CPZ D (middle) and CPZ R (right) mice showed decreased StAR immunoreactive area in the CPZ D group. Scale bar = 75 μm. D, mRNA levels (mean ± SEM) of mitochondrial proteins and microsomal neurosteroidogenic enzymes in the hippocampus. Levels of the voltage-dependent anion channel (VDAC) and 18-kDa translocator protein (TSPO) mRNA did not differ among the CTRL, CPZ D and CPZ R groups, although TSPO mRNA reached higher levels in CPZ D mice. Levels of mRNA for cholesterol-side chain cleavage enzyme (P450scc) were decreased in CPZ D mice (*P < 0.05) and increased in CPZ R mice (*P < 0.05). The last group was not different from controls (not significant).Variations of the mRNA of 3β-hydroxysteroid dehydrogenase (3β-HSD) did not differ significantly between control, CPZ D and CPZ R groups. Levels of mRNA for 5α-reductase were decreased in CPZ D mice (***P < 0.001) and increased in the CPZ R group (**P < 0.01). The last group was not different from controls (not significant). Data obtained by ANOVA followed by Newman-Keuls tests (n = 5 animals per group) . B2, The number of astrocytes GFAP+ was increased in CPZ D vs CTRL mice (***P < 0.001) and decreased in CPZ R mice (***P < 0.001; not significant vs CTRL). B3, Levels of tumor necrosis factor (TNF)α mRNA were increased in CPZ D mice (**P < 0.01 vs control) and decreased in the CPZ R group (**P < 0.01). C1-C3, Levels of StAR, P450scc and 5α-reductase mRNA were decreased in CPZ D mice (*P < 0.05 vs control) and restored to CTRL levels in the CPZ R group (*P < 0.05 for StAR and **P < 0.01 for P450scc and 5α-reductase vs CPZ D).Data obtained were analysed by ANOVA followed by the Newman-Keuls test (n = 5 mice per group) Figure 1F , left and right, respectively). In this experiment, the number of GFAP+ astrocytes showed significant group differences with respect to the results of the ANOVA (F 2,9 = 22.55; P < 0.001) and was markedly increased in the stratum lacunosum moleculare of the hippocampus of CPZ D vs CTRL mice (P < 0.001) ( Figure 1G ). This glial response was linked to inflammation, as shown by significant changes in TNFα (F 2,8 = 35.08 P < 0.0001), a main proinflammatory cytokine of activated astrocytes and microglia. 28 Thus, in parallel to reactive gliosis, TNFα mRNA showed a three-fold induction in CPZ D mice (P < 0.001) and a reduction in CPZ R mice (P < 0.01 vs CPZ D) ( Figure 1H ).
After demonstrating the effectiveness of our protocol to produce demyelination and remyelination and changes of glial cells during these two periods, we studied neurosteroidogenesis by first measuring molecules belonging to the transduceosome complex. by ANOVA. StAR mRNA and the corresponding protein immunoreactive area were reduced by 30% (P < 0.01) and by 50% (P < 0.05),
respectively, compared to CTRL. Subsequent remyelination restored these parameters because CPZ R was not different from CTRL levels (Figure 2A,B) . Figure 2C shows a low signal for immunoreactive StAR in the CA3 hippocampus region (CPZ D) compared to the same region of CTRL and CPZ R mice. The transduceosome molecules VDAC and TSPO were also evaluated at the transcriptional level. Figure 2D shows no statistical difference in the levels of VDAC and TSPO during the demyelination and remyelination periods. However, TSPO showed a trend for an increase in CPZ D and a decrease in CPZ R. These changes may be a result of changes of microglia because TSPO is a recognised marker of these cells. The mRNAs for P450scc and 5α-reductase showed significantly intergroup differences (F 2,10 = 6.31, P < 0.05 and F 2,10 = 16.36, P < 0.001, respectively). Both mRNAs were down-regulated by 30% during demyelination of CPZ D mice (P < 0.05 and P < 0.001, respectively, vs CTRL) ( Figure 2D ) and were recovered to control levels in CPZ R mice (not significant vs CTRL). 3β-HSD mRNA showed a large intragroup variation, particularly in the remyelinated group, although this was without any statistical significance.
These results suggest that, in the hippocampus, cuprizone treatment produced demyelination, induced a proinflammatory status (IBA1, GFAP, TNFα) and down-regulated some neurosteroidogenic parameters (StAR, P450scc, aromatase). Instead, spontaneous remyelination following the removal of cuprizone recovered myelin formation, decreased the glial reaction and neuroinflammation, and up-regulated neurosteroidogenesis.
| Cortical myelin, glial reaction and neurosteroidogenesis in CPZ D and CPZ R mice
Cuprizone treatment targets myelin of several brain regions.
37,38
Therefore, we also determined the effectiveness of our cuprizone feeding protocol to influence myelin, glial cells and neurosteroido- We also observed activation of glial cells in the cortex area following cuprizone intoxication (ANOVA for IBA1 F 2,9 = 13.72; P < 0.001, GFAP F 2,9 = 56.29; P < 0.0001) ( Figure 3B1-B3) . Thus, the number of IBA1+ microglial cells ( Figure 3B1 ) and GFAP+ cells per area ( Figure 3B2 ) was duplicated in CPZ D mice compared to CTRL levels (P < 0.01 and P < 0.001, respectively). Simultaneous to glial reactivity, the levels of the proinflammatory cytokine TNFα ( Figure 3B3 ) were also elevated in the demyelinated group (P < 0.01 vs CTR). Conversely, on remyelination day 14, microglia ( Figure 3B1 ), astrocyte reaction ( Figure 3B2 ), as well as the proinflammatory F I G U R E 4 Myelin, glial reaction and neurosteroidogenic parameters in the corpus callosum. A1, Levels of myelin basic protein (MBP) mRNA were decreased in demyelinated (cuprizone [CPZ] D) mice (*P < 0.5 vs control) and increased in the remyelinated (CPZ R) group (**P < 0.01 vs CPZ D; not significant vs control [CTRL]). A2, Sudan Black staining was decreased in CPZ D mice (**P < 0.01 vs CTRL) and increased in CPZ R mice (***P < 0.001; not significant vs CTRL). A3, Photomicrographs from corpus callosum of CTRL (left) CPZ D (middle) and CPZ R (right) mice showed a loss of myelin stained with Sudan Black in the CPZ D group. Scale bar = 100 μm. B1, Quantitative data showed an increased number of microglial cells/mm 2 in CPZ D mice (***P < 0.001 vs CTRL) and decreased IBA+ cells in CPZ R mice (***P < 0.001; CPZ R **P < 0.01 vs CTRL). B2, The number of astrocytes GFAP+ was increased in CPZ D vs CTRL mice (***P < 0.001) and decreased in CPZ R mice (*P < 0.5; CPZ R ***P < 0.001 vs CTRL). B3, Levels of TNFα mRNA were increased in CPZ D mice (***P < 0.001 vs control) and remained at the same level in the CPZ R group (not significant vs CPZ D). B4, Photomicrographs from the corpus callosum of CTRL (left), CPZ D (middle) and CPZ R (right) mice showed an intense glial reaction containing highly activated microglial cells in the CPZ D group. Scale bar = 50 μm. C1-C3, Levels of StAR, P450scc and 5α-reductase mRNA were decreased in CPZ D mice (*P < 0.05 for StAR and 5α-reductase; ***P < 0.001 for P450scc vs control) and remained low in the CPZ R group for StAR and P450scc (not significant vs CPZ D). 5α-reductase mRNA levels were increased in CPZ R mice (*P < 0.05 vs CPZ D). Data obtained were analysed by ANOVA followed by the Newman-Keuls test (n = 5 mice per group) mediator TNFα (Figure 3B3 ), were significantly reduced vs CPZ D (P < 0.05 for IBA1; P < 0.001 for GFAP; P < 0.01 for TNFα). Thus, spontaneous remyelination returned abnormalities of glial cells and an inflammatory marker to levels of CTRL mice.
To evaluate neurosteroidogenesis in the cerebral cortex, we determined the transcripts of StAR, P450scc and 5α-reductase.
We concentrated on these molecules because they showed an opposite modulation in the hippocampus of CPZ D and CPZ R mice (Figure 1 ). The three parameters disclosed significant differences by ANOVA (StAR: F 2,14 = 7.79, P < 0.01; P450scc: F 2,11 = 7,33, P < 0.01; 5α-reductase: F 2,13 = 5.31, P < 0.05). In agreement with the findings obtained in the hippocampus, the mRNAs for StAR ( Figure 3C1 ), P450scc ( Figure 3C2 ) and 5α-reductase ( Figure 3C3) were down-regulated in the cortex during cuprizone-induced demyelination (P < 0.05 vs CTRL for the three transcripts). By contrast, increased mRNAs for StAR (P < 0.05), P450scc and 5α-reductase (P < 0.01 for both) were found in remyelinated CPZ R mouse vs CPZ D mice, reaching levels similar to those of CTRL mice. In the cerebral cortex, therefore, cuprizone demyelination was accompanied by astrogliosis, microgliosis, inflammation and decreased neurosteroidogenesis, whereas spontaneous remyelination normalised myelin expression, attenuated gliosis and inflammation, and increased neurosteroidogenesis. 
| Corpus callosum myelin, glial reaction and neurosteroidogenesis in CPZ D and CPZ R mice
TNFα mRNA, an index of tissue inflammation, was increased to the same extent in CPZ D and CPZ R mice (P < 0.001 in both cases vs CTRL ( Figure 4B3 ).
Immunofluorescence images of IBA1 taken from the corpus callosum of CPZ D mice ( Figure 4B4 , centre) showed enhanced microglia activation compared to the neocortex and hippocampus. This microglia showed a globoid activated phenotype and disposed "in chains" along the analysed area. A notorious pathological response was also found for CPZ D astrocytes, which showed a hyperreactive phenotype bearing several GFAP+ processes (not shown).
In analogy with the hippocampus and cortex, neurosteroidogenic molecules of corpus callosum showed a decreased expression of StAR, P450scc and 5α-reductase mRNA after cuprizone feeding. (ANOVA: F 2,10 = 5.96, P < 0.5; F 2,10 = 15.28, P < 0.001; F 2,9 = 6.11, P < 0.5, respectively). Post-hoc comparisons showed significant differences for StAR (P < 0.05), 5α-reductase (P < 0.05) and P450scc (P < 0.001) vs CTRL ( Figure 4C1-3) . However, when animals switched from cuprizone to a normal diet, the expression of these transcripts remain stable at low levels except for 5α-reductase, which was recovered to control measurement. Thus, remyelination and decreased glial reaction of the corpus callosum was not accompanied by enhanced expression of all neurosteroidogenic molecules.
Although microglial cell number decreased upon remyelination in the three areas analysed (Figure 5A , cortex; Figure 5B , hippocampus; and Figure 5C , corpus callosum), corpus callosum microglial cells still showed an activated round phenotype with thick processes ( Figure 5C ) in contrast to arborised grey matter cells, which contained thinner processes and showed a resting appearance ( Figure 5A,B) . Thus, neuroinflammation of the corpus callosum as a result of persistent high levels of TNFα by activated glial cells may prevent full recovery of neurosteroidogenesis.
| Immunostaining for StAR and markers of neurones, oligodendrocytes and astrocytes
Studies were also performed to determine the localisation of StAR protein in control and treated animals. An extensive neuronal localisation was demonstrated for StAR in both groups in hippocampus, particularly in the CA3 region, as previously shown in Figure 2C .
In addition, using NeuN staining, we showed that STAR+ neurones were abundantly found in the cerebral cortex ( Figure 5F ), whereas
StAR immunoreaction in the corpus callosum was scarce (not shown).
GFAP labelling indicated that most of the reactive astrocytes found in demyelinated animals colocalised with StAR in cortex. Similar images were found for the hippocampus and corpus callosum. Figure 5I shows the presence of GFAP/StAR double positive cells in the cortex (arrows). Instead, colocalisation with CC1 marker showed that the majority of oligodendrocytes were devoid of StAR protein in both groups in the three areas analysed. Figure 5L shows the absence of StAR immunostaining in a CC1 cell (arrow) in the cortex of a cuprizone-treated animal.
| D ISCUSS I ON
Cuprizone treatment is useful for studying the factors involved in demyelination and remyelination, resembling the relapsing-remitting form of MS. 39 Our results obtained in mice subjected to cuprizoneinduced demyelination revealed that the expression of neurosteroidogenic proteins and enzymes decreased in parallel with myelin loss and glial proliferation and reactivity. These parameters were restored during spontaneous remyelination, suggesting that remyelination and neurosteroidogenesis may be interconnected events, at least in grey matter regions such as the hippocampus and cerebral cortex.
In the present study, the loss of myelin induced by cuprizone in Regarding the mechanism involved in the abnormal steroidogenesis of cuprizone-treated mice, studies indicate that steroidogenic genes and proteins, such as StAR and P450 enzymes, are damaged by products released from reactive microglia and astrocytes. 41, 42 Under normal conditions, StAR is found in mitochondria from neurones and astrocytes 43, 44 and VDAC is found predominantly in neuronal mitochondria, 14, 45, 46 whereas P450scc is a mitochondrial-based enzyme found in neurones, astrocytes and oligodendrocytes. 46, 47 Astrocytes are a major site for the expression of 3β-HSD, highlighting a key role of this cell type in all basic steroidogenic pathways. 48 Five α-reductase type 1 is abundantly expressed in the brain and is mainly localised in glial cells, such as astrocytes and oligodendrocytes. 49 The production of steroids and the mechanisms regulating its An important question remains for the present study concerning the mechanisms producing changes in neurosteroidogenesis. It is possible that the recovery in the expression of the enzymes after the toxic removal is related to lower levels of neuroinflammatory mediators considering that inflammatory molecules such as TNFα have been associated with mitochondrial dysfunction and ROS production. 53 Additionally, mitochondrial dysfunction also contributes to the loss of the homeostatic mechanism of cholesterol trafficking, which has a central role in the microglial-astrocyte-neurone circuitry and steroid hormone synthesis. 54 Thus, in the contex of lower inflam- 30 Interestingly, mitochondrion is a target of progestin action. Pharmacological studies describe an increase in electron transport chain and a decrease oxidative stress after exogenous administration of progesterone and oestrogen. 79, 80 Therefore, steroids may produce a "feed forward" mechanism stabilising mitochondria and stimulating their own synthesis.
Based on supporting reports, the possibility exists that the principal source of steroids regulating myelin and glial cells in the cuprizone demyelination and remyelination phases derives from neurosteroidogenesis. The results of previous studies indicate that ovariectomisation does not influence the extent of cuprizone demyelination. 29 Furthermore, cuprizone treatment disrupts oestrous cyclicity from the first week of intake and reduces uterine weight, suggesting a decreased level in circulating ovarian hormone levels. After the removal of the quelator, normalisation of the oestrous cycles may take more than 3 weeks. 81 Therefore, the recovery of steroidogenic enzymes and myelin after 15 days may be independent of ovarian steroids.
Cuprizone toxicity elicits an inflammatory reaction revealed by reactive gliosis and up-regulation of pro-inflammatory cytokines such us TNFα. The latter is known to play an important role in oligodendrocyte death and demyelination. 67 Oestrogens and progesterone have shown anti-inflammatory actions by repressing the DNA-binding activity of nuclear factor-kappa B (NF-κB) and transcription of NF-κB targeted proinflammatory cytokines including TNF-α. 82 Moreover, progesterone also switches microglial cells from a proinflammatory (M1) to an anti-inflammatory (M2) phenotype in cuprizone demyelination. 83 Therefore, our data suggest that increased neurosteroidogenesis during remyelination may also attenuate inflammatory mediators in the hippocampus and neocortex.
Among the three areas analysed, the microglial reaction, based on the number and morphology of the cells, was stronger in the demyelinated corpus callosum compared to the hippocampus or neocortex, in accordance with previously published data. 70 Although microglial density was dampened after cuprizone removal in the three brain regions, activated phenotype and proinflammatory products such as TNFα remained elevated in the corpus callosum. It is possible that the amount of myelin debris generated following demyelination in the myelin rich corpus callosum and the myelin sparse grey matter may drive microglial activation in different magnitudes considering the very active role of these cells in cuprizone-induced demyelination. 67 Therefore, it is feasible that normalisation of inflammation requires a longer time in the first region compared to the hippocampus or cortex.
In the cortex of control animals the density and proliferation rate of OPCs is lower compared to the corpus callosum. 70 Here, the immunoreactivity for MBP and the amount of oligodendrocytes (not shown) upon cuprizone treatment and subsequent remyelination followed the same dynamics in both grey and white matter structures, despite obvious differences in myelination.
Although astrocyte proliferation was observed in the brain regions under investigation, it was more pronounced in white matter similar to microglia in coincidence with higher myelin debris during a demyelinating event. Interestingly, these results agree with the notion that astrocytes are responsible for the recruitment of microglia and that the latter removes myelin debris and promotes remyelination. 84 In this scenario, callosal mitochondria and microsomal-based neurosteroidogenesis did not recover completely. The elevation in 5α-reductase expression may be a result of the increased number of oligodendrocytes. Because this enzyme exhibited a five-fold higher activity in oligodendrocytes, its elevation in the corpus callosum of CPZ R might lead to high levels of the 5α-reduced derivatives from progesterone or testosterone such as 5α-dihydroprogesterone and 5α-dihydrotestosterone. 21 In summary, we have shown that, during the remyelination period, increased neurosteroidogenesis plus reduced neuroinflammation and glial reaction associate with enhanced myelin synthesis in the hippocampus and neocortex of cuprizone-treated mice. The validity of preclinical studies should be considered when explaining the events taking place in the relapsing-remitting form of MS patients. 
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